Puma Biotechnology Inc (NAS:PBYI)
$ 7.69 -0.24 (-3.03%) Market Cap: 391.42 Mil Enterprise Value: 305.83 Mil PE Ratio: 16.02 PB Ratio: 3.05 GF Score: 53/100

Puma Biotechnology Inc at TD Cowen Healthcare Conference Transcript

Mar 2, 2026 / 07:30 PM GMT
Release Date Price: $6.42 (+12.63%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

PBYI.OQ - Puma Biotechnology Inc
Puma Biotechnology Inc at TD Cowen Healthcare Conference
Mar 02, 2026 / 07:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Welcome back to the forty-sixth annual TD Cowan Healthcare Conference. Mark Fram from the biotech team here at TD Cowan. In the next session, we're really pleased to have with us, Alan Ehrech, the CEO of Puma Biotech, to, talk about their commercial, continued commercialization of Nelix, but, also some, pipeline updates that are going to be coming in the next quarter or two, from Alice Herta. With that, I'll hand it over to Alan.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Great.

Thank you, Mark.

Just a reminder, I'll be making forward
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot